Clorox (CLX)
(Delayed Data from NYSE)
$146.48 USD
-1.02 (-0.69%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $146.47 -0.01 (-0.01%) 7:58 PM ET
3-Hold of 5 3
D Value B Growth B Momentum C VGM
Income Statements
Fiscal Year end for The Clorox Company falls in the month of June .
All items in Millions except EPS data.
6/30/23 | 6/30/22 | 6/30/21 | 6/30/20 | 6/30/19 | |
---|---|---|---|---|---|
Sales | 7,389 | 7,107 | 7,341 | 6,721 | 6,214 |
Cost Of Goods | 4,481 | 4,562 | 4,142 | 3,658 | 3,486 |
Gross Profit | 2,908 | 2,545 | 3,199 | 3,063 | 2,728 |
Selling & Adminstrative & Depr. & Amort Expenses | 2,500 | 1,795 | 2,272 | 1,789 | 1,604 |
Income After Depreciation & Amortization | 408 | 750 | 927 | 1,274 | 1,124 |
Non-Operating Income | -80 | -37 | 72 | 10 | -3 |
Interest Expense | 90 | 106 | 99 | 99 | 97 |
Pretax Income | 238 | 607 | 900 | 1,185 | 1,024 |
Income Taxes | 77 | 136 | 181 | 246 | 204 |
Minority Interest | 12 | 9 | 9 | 0 | 0 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | 161 | 471 | 719 | 939 | 820 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | 149 | 462 | 710 | 939 | 820 |
Depreciation Footnote | 6/30/23 | 6/30/22 | 6/30/21 | 6/30/20 | 6/30/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | 1,089 | 974 | 1,467 | 1,454 | 1,304 |
Depreciation & Amortization (Cash Flow) | 681 | 224 | 540 | 180 | 180 |
Income After Depreciation & Amortization | 408 | 750 | 927 | 1,274 | 1,124 |
Earnings Per Share Data | 6/30/23 | 6/30/22 | 6/30/21 | 6/30/20 | 6/30/19 |
---|---|---|---|---|---|
Average Shares | 124.18 | 123.91 | 128.00 | 127.67 | 129.79 |
Diluted EPS Before Non-Recurring Items | 5.09 | 4.10 | 7.25 | 7.36 | 6.32 |
Diluted Net EPS (GAAP) | 1.20 | 3.73 | 5.58 | 7.36 | 6.32 |
Fiscal Year end for The Clorox Company falls in the month of June .
All items in Millions except EPS data.
3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 | |
---|---|---|---|---|---|
Sales | NA | 1,990.00 | 1,386.00 | 2,019.00 | 1,915.00 |
Cost Of Goods | NA | 1,124.00 | 854.00 | 1,157.00 | 1,115.00 |
Gross Profit | NA | 866.00 | 532.00 | 862.00 | 800.00 |
SG&A, R&D, and Dept/Amort Expenses | 0.00 | 540.00 | 470.00 | 578.00 | 997.00 |
Income After SG&A, R&D, and Dept/Amort Expenses | 0.00 | 326.00 | 62.00 | 284.00 | -197.00 |
Non-Operating Income | NA | 178.00 | -12.00 | -26.00 | -24.00 |
Interest Expense | NA | 26.00 | 21.00 | 21.00 | 24.00 |
Pretax Income | NA | 136.00 | 29.00 | 237.00 | -245.00 |
Income Taxes | NA | 40.00 | 4.00 | 56.00 | -36.00 |
Minority Interest | NA | 3.00 | 3.00 | 5.00 | 2.00 |
Investment Gains/Losses | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | NA | 96.00 | 25.00 | 181.00 | -209.00 |
Extras & Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | NA | 93.00 | 22.00 | 176.00 | -211.00 |
Earnings Per Share Data | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 |
---|---|---|---|---|---|
Average Shares | NA | 124.62 | 124.65 | 124.64 | 123.65 |
Diluted EPS Before Non-Recurring Items | NA | 2.16 | 0.49 | 1.67 | 1.51 |
Diluted Net EPS (GAAP) | NA | 0.75 | 0.17 | 1.43 | -1.71 |